References
- Srivastava A, Singh R, Varshney S, Gupta P, Bist S, Bhagat S, et al. Microbiological evaluation of an active tubotympanic type of chronic suppurative otitis media. Nepalese J ENT Head Neck Surg 2010;1:14–16.
- Bluestone CD, Gates G, Klein JO. Panel reports: 1. definitions, terminology, and classification of otitis media. Ann Otol Rhinol Laryngol 2002; 111:8–18.
- Choi HG, Park KH, Park SN, Jun BC, Lee DH, Yeo SW. The appropriate medical management of methicillin-resistant Staphylococcus aureus in chronic suppurative otitis media. Acta Otolaryngol 2010;130:42–6.
- Ahmad S. Antibiotics in chronic suppurative otitis media: a bacteriologic study. Egypt J Ear Nose Throat Allied Sci 2013;14:191–4.
- Lorente M, Ballano A, Juanes A, Pastor MA, Cuevas J. Blue-gray pigmentation in trunk and extremities in a 71-year-old man. JAMA Dermatol 2013;149:1111–12.
- Uchida S. Once-daily levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: An open study. J Am Acad Dermatol 2012;66(4):AB17.
- Abes G, Espallardo N, Tong M, Subramaniam KN, Hermani B, Lasiminigrum L, et al. A systematic review of the effectiveness of ofloxaxin otic solution for the treatment of suppurative otitis media. ORL J Otorhinolaryngol Relat Spec 2003;65:106–16.
- Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23:2709–28.
- Ur-Rehman T. Controlled release gel formulations and preclinical screening of drug candidates. Dissertation, Umeå University. Sweden: 2011.
- Hatch A. Combating antibiotic resistance through development of a novel antimicrobial delivery vehicle. Thesis, Utah State University. USA: 2011.
- Ma WD, Xu H, Wang C, Nie SF, Pan WS. Pluronic F127-g-poly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. Int J Pharm 2008;350:247–56.
- Fawaz F, Koffi A, Guyot M, Millet P. Comparative in vitro–in vivo study of two quinine rectal gel formulations. Int J Pharm 2004;280:151–62.
- Chang JY, Oh Y-K, Choi H-G, Kim YB, Kim C-K. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int J Pharm 2002;241:155–63.
- Baumann I, Gerendas B, Plinkert PK, Praetorius M. General and disease-specific quality of life in patients with chronic suppurative otitis media – a prospective study. Health Qual Life Outcomes 2011;9:48.
- Jensen RG, Homøe P, Andersson M, Koch A. Long-term follow-up of chronic suppurative otitis media in a high-risk children cohort. Int J Pediatr Otorhinolaryngol 2011;75:948–54.
- Kirkeby S, Friis M, Mikkelsen H, Cayé-Thomasen P. Bacterial adherence in otitis media: determination of N-acetylgalactosamine (GalNAc) residues in the submucosal glands and surface epithelium of the normal and diseased Eustachian tube. Microb Pathog 2011;51:48–57.
- Khoo X, Simons EJ, Chiang HH, Hickey JM, Sabharwal V, Pelton SI, et al. Formulations for trans-tympanic antibiotic delivery. Biomaterials 2012;34:1281–8.
- Akash MSH, Rehman K, Sun H, Chen S. Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist. Pharm Dev Technol 2014;19:278–84.
- Blonder JM, Baird L, Fulfs JC, Rosenthal GJ. Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel. Life Sci 1999;65:PL261–PL6.
- Hou W, Li X, Xiao H. [Formation characteristics and significance of bacteria biofilm in middle ear mucosa of rats with chronic suppurative otitis]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2012;26:30; in Chinese.